Increased inflammasome activity in markedly ill psychiatric patients: An explorative study.


Journal

Journal of neuroimmunology
ISSN: 1872-8421
Titre abrégé: J Neuroimmunol
Pays: Netherlands
ID NLM: 8109498

Informations de publication

Date de publication:
15 02 2020
Historique:
received: 14 08 2019
revised: 20 11 2019
accepted: 25 11 2019
pubmed: 2 12 2019
medline: 10 7 2020
entrez: 2 12 2019
Statut: ppublish

Résumé

The aim of this study was to investigate inflammatory perturbations in 40 patients with severe and complex psychiatric disorders by studying the activity of the NLRP3 inflammasome, with a trans-diagnostic approach. Gene expression of CASP1, NLRP3, PYCARD, IL1B, IL1RN, TNF showed a significant increase in the patient group compared to a matched control group. Plasma levels of IL1Ra, IL-18, TNF, IL-6 and CRP were increased in the patient group. Within the patient group, increased gene expression of inflammatory markers correlated with increased disease severity. The findings support the inflammation hypothesis for markedly ill psychiatric patients across diagnostic groups.

Identifiants

pubmed: 31786499
pii: S0165-5728(19)30416-3
doi: 10.1016/j.jneuroim.2019.577119
pii:
doi:

Substances chimiques

Biomarkers 0
IL1RN protein, human 0
Inflammasomes 0
Interleukin 1 Receptor Antagonist Protein 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
NLRP3 protein, human 0
Caspase 1 EC 3.4.22.36

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

577119

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Ulrika Hylén (U)

University Health Care Research Center, Faculty of Medicine and Health, Örebro University, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Inflammatory Response and Infection Susceptibility Centre, (iRiSC), Örebro University, Örebro, Sweden. Electronic address: ulrika.hylen@regionorebrolan.se.

Daniel Eklund (D)

School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Inflammatory Response and Infection Susceptibility Centre, (iRiSC), Örebro University, Örebro, Sweden. Electronic address: daniel.eklund@oru.se.

Mats Humble (M)

University Health Care Research Center, Faculty of Medicine and Health, Örebro University, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Inflammatory Response and Infection Susceptibility Centre, (iRiSC), Örebro University, Örebro, Sweden. Electronic address: mats.humble@regionorebrolan.se.

Jakub Bartoszek (J)

School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Eva Särndahl (E)

School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Inflammatory Response and Infection Susceptibility Centre, (iRiSC), Örebro University, Örebro, Sweden. Electronic address: eva.sarndahl@oru.se.

Susanne Bejerot (S)

University Health Care Research Center, Faculty of Medicine and Health, Örebro University, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Inflammatory Response and Infection Susceptibility Centre, (iRiSC), Örebro University, Örebro, Sweden. Electronic address: susanne.bejerot@oru.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH